K Abbrederis

407 total citations
29 papers, 224 citations indexed

About

K Abbrederis is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, K Abbrederis has authored 29 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 6 papers in Genetics and 4 papers in Oncology. Recurrent topics in K Abbrederis's work include Acute Myeloid Leukemia Research (9 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). K Abbrederis is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). K Abbrederis collaborates with scholars based in Austria and Germany. K Abbrederis's co-authors include H Braunsteiner, F. Schmalzl, Alois Lang, Alexander Dzien, Heinz Drexel, H. Asamer, Josef R. Patsch, H. Huber, G Konwalinka and C. Huber and has published in prestigious journals such as Blood, Pain and Journal of Molecular Medicine.

In The Last Decade

K Abbrederis

27 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Abbrederis Austria 10 85 72 49 45 45 29 224
Alexis Melton United States 9 106 1.2× 20 0.3× 5 0.1× 39 0.9× 63 1.4× 19 177
Elspeth McPherson United States 9 11 0.1× 15 0.2× 4 0.1× 61 1.4× 15 0.3× 13 277
Scott Rb United States 9 34 0.4× 47 0.7× 25 0.6× 46 1.0× 43 459
Nadira Azzi Belgium 8 91 1.1× 137 1.9× 80 1.8× 37 0.8× 12 249
Ernest Bilić Croatia 8 74 0.9× 29 0.4× 2 0.0× 24 0.5× 13 0.3× 34 165
Fatih Azık Türkiye 10 131 1.5× 60 0.8× 49 1.1× 33 0.7× 51 271
Francisco Lendínez Spain 9 141 1.7× 67 0.9× 27 0.6× 51 1.1× 18 323
M. Eden Childs United States 5 66 0.8× 14 0.2× 2 0.0× 9 0.2× 51 1.1× 7 333
Toshihiko Asahina Japan 9 185 2.2× 74 1.0× 11 0.2× 59 1.3× 12 327
Francesca Guidotti Italy 10 74 0.9× 63 0.9× 13 0.3× 26 0.6× 23 214

Countries citing papers authored by K Abbrederis

Since Specialization
Citations

This map shows the geographic impact of K Abbrederis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Abbrederis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Abbrederis more than expected).

Fields of papers citing papers by K Abbrederis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Abbrederis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Abbrederis. The network helps show where K Abbrederis may publish in the future.

Co-authorship network of co-authors of K Abbrederis

This figure shows the co-authorship network connecting the top 25 collaborators of K Abbrederis. A scholar is included among the top collaborators of K Abbrederis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Abbrederis. K Abbrederis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drexel, Heinz, et al.. (2008). Pumpengesteuerte kontinuierliche subkutane Opiat-Infusion zur Behandlung schwerster Schmerzen*. DMW - Deutsche Medizinische Wochenschrift. 110(27). 1063–1067.
2.
Thaler, J., Thomas Kühr, Günther Gastl, et al.. (2008). Rekombinantes Interferon α-2c bei Ph-positiver chronischer myeloischer Leukämie: Ergebnisse einer multizentrischen Phase-II-Studie. DMW - Deutsche Medizinische Wochenschrift. 116(19). 721–728.
3.
Mühlberger, V., et al.. (2008). Myokardinfarkt unter Ergotamin-Medikation bei einem Jugendlichen mit normalen Koronararterien. DMW - Deutsche Medizinische Wochenschrift. 108(16). 623–626. 2 indexed citations
4.
Eberle, Julia, et al.. (2002). Steinepisode in überzähliger dritter Niere. Der Urologe. 41(4). 362–363. 2 indexed citations
5.
Hilbe, Wolfgang, Ute Apfelbeck, Michael Fridrik, et al.. (1998). Interferon-α for the treatment of elderly patients with chronic myeloid leukaemia. Leukemia Research. 22(10). 881–886. 9 indexed citations
6.
Lang, Alois, K Abbrederis, Alexander Dzien, & Heinz Drexel. (1991). Treatment of Severe Cancer Pain by Continuous Infusion of Subcutaneous Opioids. Recent results in cancer research. 121. 51–57. 3 indexed citations
7.
Drexel, Heinz, Alexander Dzien, Alois Lang, et al.. (1989). Treatment of severe cancer pain by low-dose continuous subcutaneous morphine. Pain. 36(2). 169–176. 56 indexed citations
8.
Gastl, Guenther, C. Nerl, W. Aulitzky, et al.. (1989). Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.. PubMed. 3(6). 453–60. 12 indexed citations
9.
Seewann, H. L., Günther Gastl, Alois Lang, et al.. (1988). Interferon-alpha-2 in the treatment of idiopathic myelofibrosis. Annals of Hematology. 56(4). 161–163. 19 indexed citations
10.
Abbrederis, K, et al.. (1985). [Rhabdomyolysis as a late complication of anesthesia--a case of malignant hyperthermia?].. PubMed. 97(21). 813–6. 1 indexed citations
11.
Abbrederis, K, et al.. (1982). Unreifzellige Leuk�mien im fortgeschrittenen Lebensalter. Annals of Hematology. 44(5). 289–296. 1 indexed citations
12.
Schmalzl, F., et al.. (1978). Detection of Cytochemical and Morphological Anomalies in ‘Preleukemia’. Acta Haematologica. 59(1). 1–18. 19 indexed citations
13.
Abbrederis, K, F. Schmalzl, & H Braunsteiner. (1976). Zur Bedeutung der PAS-positiven Myeloblastenleuk�mie. Annals of Hematology. 33(2). 103–108. 1 indexed citations
14.
Schmalzl, F., D. Huhn, K Abbrederis, & H Braunsteiner. (1974). Acute lymphocytic leukemia cytochemistry and ultrastructure. Annals of Hematology. 29(2). 87–95. 4 indexed citations
15.
Abbrederis, K, G. Michlmayr, & F. Schmalzl. (1974). [Acute lymphatic leukemia in adults. Therapy and prognosis in comparison with acute myelogenous leukemia].. PubMed. 69(10). 427–31. 4 indexed citations
16.
Abbrederis, K, F. Schmalzl, & H Braunsteiner. (1973). Zur Typenverteilung, Alters- und Geschlechtsdisposition der akuten Leukämien des Erwachsenen. Annals of Hematology. 27(5). 302–306. 2 indexed citations
17.
Schmalzl, F., K Abbrederis, & H Braunsteiner. (1969). Cytochemische Untersuchungen an den Rundzelleninfiltraten bei chronischen oder protrahiert verlaufenden Virus-Hepatitiden. Journal of Molecular Medicine. 47(5). 256–260. 1 indexed citations
18.
Abbrederis, K, F. Schmalzl, & H Braunsteiner. (1969). [Differential diagnosis of acute leukemia by means of cytochemical methods].. PubMed. 99(40). 1425–30. 20 indexed citations
19.
Schmalzl, F., H. Huber, H. Asamer, K Abbrederis, & H Braunsteiner. (1969). Cytochemical and Immunohistologic Investigations on the Source and the Functional Changes of Mononuclear Cells in Skin Window Exudates. Blood. 34(2). 129–140. 23 indexed citations
20.
Schmalzl, F., K Abbrederis, & H Braunsteiner. (1968). Über das Verhalten leukämischer Monocyten bei der lokalen Entzündung. Journal of Molecular Medicine. 46(17). 962–962. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026